Mydecine Innovations Group Inc
F:0NF0
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Mydecine Innovations Group Inc
F:0NF0
|
CA |
|
GLP J-REIT
OTC:GLPJF
|
JP |
|
Matsui Securities Co Ltd
OTC:MTSEF
|
JP |
|
C
|
Columbus A/S
XBER:P1F
|
DK |
|
H
|
Hemogenyx Pharmaceuticals PLC
F:5HU
|
UK |
|
Organogenesis Holdings Inc
F:2PQ
|
US |
|
C
|
Cts Eventim AG & Co KgaA
F:EVD
|
DE |
|
Toukei Computer Co Ltd
OTC:TKCCF
|
JP |
|
Litalico Inc
F:9N0
|
JP |
Shareholder Yield
Current shareholder yield for 0NF0 is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
0NF0 Price
Mydecine Innovations Group Inc
| Average Annual Return | -85.33% |
| Standard Deviation of Annual Returns | 15.18% |
| Max Drawdown | -100% |
| Market Capitalization | 62.6m EUR |
| Shares Outstanding | 61 755 400 |
| Percentage of Shares Shorted |
N/A
|
0NF0 Return Decomposition
Main factors of price return
Stock Splits
0NF0's latest stock split occurred on Oct 21, 2025
The company executed a 1-for-50 stock split, meaning that for every 50 shares held, investors received 1 new share.
Before the split, 0NF0 traded at 0.05 per share. Afterward, the share price was about 0.05.
The adjusted shares began trading on Oct 21, 2025. This was stock split number 3 in 0NF0's history, following the previous one in Apr 21, 2022.